Kirill M Starostin

Effectiveness of phosphatidylcholine in alleviating steatosis in patients with non-alcoholic fatty liver disease and cardiometabolic comorbidities (MANPOWER study)

Liudmila K Palgova, Chavdar S Pavlov, Kirill M Starostin · BMJ Open Gastroenterology · 2020 · 59 citations · Full text

Medicine, Internal Medicine, Pharmacology +10

Effectiveness of phosphatidylcholine as adjunctive therapy in improving liver function tests in patients with non-alcoholic fatty liver disease and metabolic comorbidities: real-life observational study from Russia

Liudmila K Palgova, Chavdar S Pavlov, Kirill M Starostin · BMJ Open Gastroenterology · 2020 · 51 citations · Full text

Medicine, Internal Medicine, Pharmacology +17

Real-world comorbidities and treatment patterns among patients with non-alcoholic fatty liver disease receiving phosphatidylcholine as adjunctive therapy in Russia

Liudmila K Palgova, Chavdar S Pavlov, Kirill M Starostin · BMJ Open Gastroenterology · 2019 · 23 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +14

A New, Non-Invasive Scale for Steatosis Developed Using Real-World Data From Russian Outpatients to Aid in the Diagnosis of Non-Alcoholic Fatty Liver Disease

Alexey Samsonov, Chavdar S Pavlov, Vlad Ratziu et al. · Advances in Therapy · 2020 · 16 citations · Full text

Medicine, Internal Medicine, Pathology +13

Correlation of Objective Endpoints and Subjective Patient-Reported Outcomes in NAFLD Treatment with Essential Phospholipids: Real-World Data Based on Pooled Analysis of Observational Studies

М. V. Maevskaya, Alexey Samsonov, Evgeniy I. Sas et al. · Drugs - Real World Outcomes · 2021 · 15 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +12